Cargando…

Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis

BACKGROUND: In a recent study we had evidence that sulphite oxidase (SO) may be a relevant autoantigen in primary sclerosing cholangitis (PSC). Aim of the present study was, therefore, to analyse humoral and cellular immune-reactivity towards SO in these patients in more detail. METHODS: Sera from 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Preuß, Beate E., Berg, Christoph P., Werner, Christoph, Plankenhorn, Sandra, Malek, Nisar P., Klein, Reinhild
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932765/
https://www.ncbi.nlm.nih.gov/pubmed/29720090
http://dx.doi.org/10.1186/s12876-018-0787-x
_version_ 1783319863015505920
author Preuß, Beate E.
Berg, Christoph P.
Werner, Christoph
Plankenhorn, Sandra
Malek, Nisar P.
Klein, Reinhild
author_facet Preuß, Beate E.
Berg, Christoph P.
Werner, Christoph
Plankenhorn, Sandra
Malek, Nisar P.
Klein, Reinhild
author_sort Preuß, Beate E.
collection PubMed
description BACKGROUND: In a recent study we had evidence that sulphite oxidase (SO) may be a relevant autoantigen in primary sclerosing cholangitis (PSC). Aim of the present study was, therefore, to analyse humoral and cellular immune-reactivity towards SO in these patients in more detail. METHODS: Sera from 53 patients with PSC (30 untreated and 23 treated with ursodeoxycholic acid [UDCA] at time of analysis), from 422 patients with different hepatic and non-hepatic disorders, and from 50 healthy individuals were tested by ELISA for antibodies against full-length-SO (SO-fl) and its three major domains expressed in E.coli (SO-I, SO-II, SO-III). For epitope-mapping, 29 overlapping peptides were used. Peripheral blood mononuclear cells (PBMC) were obtained from 33 PSC-patients and analysed for SO-induced proliferation, production of cytokines, and expression of the activation marker cluster of differentiation (CD) 69. RESULTS: 43% of the 30 untreated and 26% of the 23 treated PSC-patients had IgG anti-SO-antibodies predominantly reacting with SO-fl, SO-I and SO-II. Antibody-reactivity decreased after UDCA-treatment. Prevalence and reactivity of anti-SO-antibodies were significantly higher in PSC than in patients with other hepatic and non-hepatic disorders. Epitope mapping revealed no distinct immuno-dominant regions within SO. Incubation of PBMC from PSC-patients (but not from controls) with SO-antigens revealed an activation of B-cells and a T-helper cell type-2 reaction pattern (production of interleukin [IL]-13, IL-10). CONCLUSIONS: PSC-patients show humoral and cellular immune response towards SO. Antibodies may be predominantly directed against conformational epitopes. SO enhances in vitro especially T-helper cell type-2 immune-reactions, which may be pro-fibrotic. SO is a detoxifying enzyme present also in bacteria; further studies analysing its role in the aetiology and pathogenesis in PSC may, therefore, be important. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12876-018-0787-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5932765
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59327652018-05-09 Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis Preuß, Beate E. Berg, Christoph P. Werner, Christoph Plankenhorn, Sandra Malek, Nisar P. Klein, Reinhild BMC Gastroenterol Research Article BACKGROUND: In a recent study we had evidence that sulphite oxidase (SO) may be a relevant autoantigen in primary sclerosing cholangitis (PSC). Aim of the present study was, therefore, to analyse humoral and cellular immune-reactivity towards SO in these patients in more detail. METHODS: Sera from 53 patients with PSC (30 untreated and 23 treated with ursodeoxycholic acid [UDCA] at time of analysis), from 422 patients with different hepatic and non-hepatic disorders, and from 50 healthy individuals were tested by ELISA for antibodies against full-length-SO (SO-fl) and its three major domains expressed in E.coli (SO-I, SO-II, SO-III). For epitope-mapping, 29 overlapping peptides were used. Peripheral blood mononuclear cells (PBMC) were obtained from 33 PSC-patients and analysed for SO-induced proliferation, production of cytokines, and expression of the activation marker cluster of differentiation (CD) 69. RESULTS: 43% of the 30 untreated and 26% of the 23 treated PSC-patients had IgG anti-SO-antibodies predominantly reacting with SO-fl, SO-I and SO-II. Antibody-reactivity decreased after UDCA-treatment. Prevalence and reactivity of anti-SO-antibodies were significantly higher in PSC than in patients with other hepatic and non-hepatic disorders. Epitope mapping revealed no distinct immuno-dominant regions within SO. Incubation of PBMC from PSC-patients (but not from controls) with SO-antigens revealed an activation of B-cells and a T-helper cell type-2 reaction pattern (production of interleukin [IL]-13, IL-10). CONCLUSIONS: PSC-patients show humoral and cellular immune response towards SO. Antibodies may be predominantly directed against conformational epitopes. SO enhances in vitro especially T-helper cell type-2 immune-reactions, which may be pro-fibrotic. SO is a detoxifying enzyme present also in bacteria; further studies analysing its role in the aetiology and pathogenesis in PSC may, therefore, be important. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12876-018-0787-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-02 /pmc/articles/PMC5932765/ /pubmed/29720090 http://dx.doi.org/10.1186/s12876-018-0787-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Preuß, Beate E.
Berg, Christoph P.
Werner, Christoph
Plankenhorn, Sandra
Malek, Nisar P.
Klein, Reinhild
Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis
title Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis
title_full Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis
title_fullStr Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis
title_full_unstemmed Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis
title_short Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis
title_sort sulphite oxidase (so) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932765/
https://www.ncbi.nlm.nih.gov/pubmed/29720090
http://dx.doi.org/10.1186/s12876-018-0787-x
work_keys_str_mv AT preußbeatee sulphiteoxidasesoamitochondrialautoantigenastargetforhumoralandcellularimmunereactionsinprimarysclerosingcholangitis
AT bergchristophp sulphiteoxidasesoamitochondrialautoantigenastargetforhumoralandcellularimmunereactionsinprimarysclerosingcholangitis
AT wernerchristoph sulphiteoxidasesoamitochondrialautoantigenastargetforhumoralandcellularimmunereactionsinprimarysclerosingcholangitis
AT plankenhornsandra sulphiteoxidasesoamitochondrialautoantigenastargetforhumoralandcellularimmunereactionsinprimarysclerosingcholangitis
AT maleknisarp sulphiteoxidasesoamitochondrialautoantigenastargetforhumoralandcellularimmunereactionsinprimarysclerosingcholangitis
AT kleinreinhild sulphiteoxidasesoamitochondrialautoantigenastargetforhumoralandcellularimmunereactionsinprimarysclerosingcholangitis